DNMT1 Antikörper (AA 1288-1632) (FITC)

Produktnummer ABIN7150106

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch DNMT1 in . Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für DNMT1 Antikörper (AA 1288-1632) (FITC) (ABIN7150106)

Target: DNMT1 (DNA (Cytosine-5)-Methyltransferase 1 (DNMT1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser DNMT1 Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Produktdetails anti-DNMT1 Antikörper (FITC)

Bindungsspezifität: AA 1288-1632

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human DNA (cytosine-5)-methyltransferase 1 protein (1288-1632AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu DNMT1

Target: DNMT1 (DNA (Cytosine-5)-Methyltransferase 1 (DNMT1))

Andere Bezeichnung: DNMT1

Hintergrund:

Background: Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance. Associates with chromatin during G2 and M phases to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development. DNA methylation is coordinated with methylation of histones. Mediates transcriptional repression by direct binding to HDAC2. In association with DNMT3B and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). Promotes tumor growth (PubMed:24623306).

Aliases: ADCADN antibody, AIM antibody, CXXC finger protein 9 antibody, CXXC-type zinc finger protein 9 antibody, CXXC9 antibody, DNA (cytosine 5 ) methyltransferase 1 antibody, DNA (cytosine-5)-methyltransferase 1 antibody, DNA methyltransferase 1 antibody, DNA methyltransferase HsaI antibody, DNA methyltransferase M.HsaI. antibody, DNA MTase antibody, DNA MTase HsaI antibody, DNMT 1 antibody, DNMT antibody, Dnmt1 antibody, DNMT1_HUMAN antibody, Dnmt1o antibody, FLJ16293 antibody, HSN1E antibody, M.HsaI antibody, MCMT antibody, Met1 antibody, MGC104992 antibody, mMmul antibody, MommeD2 antibody

UniProt: P26358

Pathways: SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion